Neuro-Bio welcomes Imogen Treger as part of the team! Imogen just finished her third year studying biochemistry at Oxford university and she is very interested in exploring biotech as a career. She was drawn towards Neuro-Bio due to the unique approach the company has for the treatment of Alzheimer’s and for this reason she has now joined as intern. She is very excited to work with the team and explore their research in more detail over the next few weeks.
LATEST NEWS
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!